$EPC

Edgewell Personal Care Q3 Earnings Call Highlights

Edgewell Personal Care (EPC) reported Q3 organic sales trends: wet shave organic sales fell 1.9% as private-label supply disruptions outweighed branded growth, while U.S. razors and blades consumption rose with higher promotions. Sun and skin care organic sales rose 5%. Adjusted operating income was $53M (9.3% margin); GAAP EPS $0.26 vs $0.46. Fiscal 2026 adjusted EPS guidance is $1.80-$2.00.

Original reporting
Published Aug 9, 2026, 10:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 10:36 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Edgewell Personal Care Q3 Earnings Call Highlights — source image
Decision brief

The 30-second read

$EPCNeutralMed
01

Why it matters

The key tradable elements are the quantified Q3 earnings/margin outcomes and the narrowed FY2026 ranges, plus management’s explanation that productivity savings and cycling prior one-time costs should support stronger Q4 performance.

02

Market read

This is a company-specific earnings and guidance update with explicit EPS, EBITDA, and free-cash-flow ranges, plus operational commentary on supply disruptions and productivity initiatives.

03

What to watch

Promotional activity and couponing changes are highlighted as drivers of share and consumption trends; traders may underweight how much of the margin and share pressure is structural versus cyclical.

Relevance 8/10Novelty 7/10Timing: post-earnings call, pre-market/early session today

Background

Edgewell’s Q3 call covered organic sales by category, margin drivers, cash flow, and a narrowed FY2026 outlook while continuing a wet-shave manufacturing consolidation.

Company-level read

Ticker impact

$EPCNeutralMedium confidence
Context

Edgewell reported Q3 results and narrowed FY2026 guidance, including adjusted EPS of $1.80 to $2.00 and margin pressure from inflation and mix.

Expected impact

Near-term volatility likely as investors weigh margin compression and promotional pressure versus the narrowed outlook and expected Q4 gross-margin expansion.

Evidence & confidence

The article provides specific Q3 profitability metrics (adjusted operating income, GAAP EPS) and a quantified FY range, but it does not include consensus comparisons or a fresh balance-sheet or capital action beyond the dividend.

Market effects

Signals ongoing margin sensitivity in personal care to commodity/input inflation, tariffs, and promotional intensity, which can influence peers’ near-term sentiment.

International wet-shave manufacturing consolidation is cited as causing longer supply disruptions in some markets, potentially affecting regional demand and service levels.

Guidance references foreign exchange and tariff effects, which can matter for multinational consumer staples positioning.

Counterpoint

The guidance midpoint is unchanged, so the market may focus less on Q3 weakness and more on whether productivity savings and gross-margin expansion actually materialize in Q4.

Key entities

  • Edgewell Personal Care

    Reported Q3 results, discussed category share and margin drivers, and narrowed fiscal 2026 guidance while maintaining the prior midpoint.

  • Little

    Management speaker who discussed the wet-shave manufacturing consolidation progress and expected improvements over time.

Related articles

$EPCMed

Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results

Edgewell Personal Care (NYSE: EPC) reported fiscal 2026 third-quarter results ended June 30, 2026. Net sales rose 1.7% to $570.1M, with organic sales up 1.1%. Adjusted EPS was $0.72, flat year over year, while GAAP diluted EPS was $0.26. The company said full-year outlook was narrowed, with adjusted EPS and EBITDA midpoints unchanged, and declared a $0.15 dividend.

$EPCMed

EDGEWELL PERSONAL CARE Co (EPC): Results of Operations and Financial Condition

EDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q3fy26-epcexhibit991.htm EX-99.1 Document Exhibit 99.1 Edgewell Personal Care Company 6 Research Drive Shelton, Conn 06484 FOR IMMEDIATE RELEASE Company Contact Chris Gough Vice President, Investor Relations 203-944-5706 Chris.Gough@Edgewell.com Edgewell Personal Care A

$EPCMedAI 8/10

Why Is Edgewell Personal Care (EPC) Stock Soaring Today

Edgewell Personal Care (EPC) shares rose 13.7% in the afternoon after the company rejected an unsolicited takeover offer from private equity firm Yellow Wood Partners, priced at $30 per share, according to reports. The board reportedly viewed the bid as too low. The stock is up 55.6% year-to-date and trades near its 52-week high.

$MUMed

Stocks making the biggest moves midday: Micron Technology, SpaceX, IBM, Flex & more

Midday movers: Micron fell over 10% amid a broader tech selloff; Marvell slid 8% and Sandisk dropped 11%. Accenture rose nearly 2% after raising its buyback by $2B to over $7B. Flex fell over 2% after COO sold 36,000 shares. IBM gained over 4% after a JPMorgan overweight upgrade. Carnival dropped 6% on weaker Q3 guidance. AMC sank 25% on a planned 95.3M-share sale.

$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.

$WTIMed

W&T Offshore Q2 Earnings Call Highlights

W&T Offshore (WTI) reported Q2 realized oil-equivalent prices of $50.23/bbl, up 11% from Q1 and about 40% vs year-end 2025. It forecast Q3 production above 35,000 boe/d midpoint. Q2 LOE was $72M and capex $10.4M. Full-year 2026 capex guidance is $20M-$25M. Management discussed surety litigation and potential damages.